FDA — authorised 17 April 1998
- Application: NDA020819
- Marketing authorisation holder: ABBVIE
- Local brand name: ZEMPLAR
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 Paricalitol in United States
FDA authorised Paricalitol on 17 April 1998
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Paricalitol approved in United States?
Yes. FDA authorised it on 17 April 1998.
Who is the marketing authorisation holder for Paricalitol in United States?
ABBVIE holds the US marketing authorisation.